HARVARD BIOSCIENCE, INC. Professional Fees
HARVARD BIOSCIENCE, INC. (HBIO) reported Professional Fees of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. professional fees for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- HARVARD BIOSCIENCE, INC. professional fees for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- HARVARD BIOSCIENCE, INC. professional fees for the quarter ending 2025-12-31 was $200.00K.
- HARVARD BIOSCIENCE, INC. professional fees for the quarter ending 2025-09-30 was $0.00.
- HARVARD BIOSCIENCE, INC. professional fees for fiscal 2025 was $541.00K, a 14.62% increase from fiscal 2024.
- HARVARD BIOSCIENCE, INC. professional fees for fiscal 2024 was $472.00K.
- HARVARD BIOSCIENCE, INC. professional fees for fiscal 2023 was $0.00.
| Period end | Professional Fees 3 month | Professional Fees 3 month as first filed | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | $200.00K derived: sum of 3 quarters · filed 2026-08-11 | $200.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $200.00K derived: sum of 2 quarters · filed 2026-05-12 | $200.00K derived: sum of 3 quarters · filed 2026-05-12 | $370.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $200.00K derived: sum of 2 quarters · filed 2026-03-13 | $370.00K derived: sum of 3 quarters · filed 2026-08-11 | $541.00K 10-K · filed 2026-03-13 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $170.00K derived: sum of 2 quarters · filed 2026-08-11 | $341.00K 10-Q · filed 2025-11-06 | $341.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $170.00K 10-Q · filed 2026-08-11 | $341.00K 10-Q · filed 2026-08-11 | $341.00K derived: sum of 3 quarters · filed 2026-08-11 | $341.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $171.00K 10-Q · filed 2026-05-12 | $171.00K derived: sum of 2 quarters · filed 2026-05-12 | $171.00K derived: sum of 3 quarters · filed 2026-05-12 | $171.00K derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-13 | $0.00 derived: sum of 3 quarters · filed 2026-03-13 | $472.00K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $472.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-11 | $472.00K 10-Q · filed 2025-08-11 | |||
| 2024-03-31 | $472.00K 10-Q · filed 2025-05-12 | $500.00K 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |